Exelixis
The Senior Scientist II (Computational Chemistry) role involves applying physics-based molecular modeling, cheminformatics, and data-driven methods to advance small-molecule drug discovery programs. The position requires expertise in molecular dynamics, free-energy calculations, and machine learning to support compound prioritization and design. This role demands strong collaboration with cross-functional teams to integrate computational results into discovery workflows and drive predictive analytics.
Headquarters
Alameda, California, United States
Company Size
1001-5000 employees
Founded
1994
Exelixis is an oncology-focused biotech company innovating cancer treatments for life. Find out how we're dedicated to giving more patients hope for the future.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Exelixis.
Exelixis Q4 2025 slides: Strong earnings growth amid oncology franchise expansion
2 days ago
Cheminformatics/Computational Chemistry Scientist
Eli Lilly and Company
Computational Chemistry Scientist
Roche
Associate Director, Computational Chemistry
Takeda Pharmaceutical Company Limited
Computational Chemistry Lead
Astellas
Scientist, Computational Medicinal Chemistry
Monte Rosa Therapeutics, Inc
Research Advisor, Computational Chemistry
Eli Lilly and Company